NDC codes

FDA NDC Directory
Product NDC (as listed)50242-140Labeler and product segments. Claims need a package NDC.
Product NDC at billing width50242-0140Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
50242-140-01502420140011 BOTTLE, PLASTIC in 1 CARTON (50242-140-01) / 28 CAPSULE in 1 BOTTLE, PLASTICMarketed from Jan 30, 2012
50242-140-86502420140861 BOTTLE, PLASTIC in 1 CARTON (50242-140-86) / 28 CAPSULE in 1 BOTTLE, PLASTICMarketed from Apr 9, 2013 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Erivedge
Generic name (nonproprietary)
vismodegib
Active ingredients
Vismodegib — 150 mg/1
Dosage form
Capsule
Route
Oral
Labeler
Genentech, Inc.NDC labeler code 50242
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 203388
Marketing start
Listing expires
Other FDA classes
Smoothened Receptor Antagonists (Mechanism)
Identifiers
Product ID 50242-140_d8b343ee-5767-4934-ad68-5164d4de5228SPL ID d8b343ee-5767-4934-ad68-5164d4de5228SPL set ID eb368bb6-80e3-4df9-8a85-91df0a2ada6aRxCUI 1242992, 1242998UNII 25X868M3DS
Pharmacologic class
Hedgehog Pathway Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450242014001 followed by a unit qualifier and the quantity

Package 50242-0140-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

ERIVEDGE is indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation. ERIVEDGE ® (vismodegib) is a hedgehog pathway inhibitor indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50242-140

What is NDC 50242-140?
50242-140 is the product NDC for Erivedge (vismodegib), Vismodegib 150 mg/1 capsule, listed with the FDA by Genentech, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Erivedge (Vismodegib).
What is the active ingredient?
Vismodegib.
Who is the labeler?
Genentech, Inc., NDC labeler code 50242. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Erivedge?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in